| ADTX 0.01 127.27% | GDC 0.0181 -15.02% | SOXS 3.59 -19.51% | GPUS 0.359 -9.78% | SRXH 0.1245 -37.59% | BITO 8.56 -1.95% | TZA 4.02 -5.85% | SPCX 185 -3.56% | MRVL 310.58 7.27% | CDT 1.02 47.19% | NVDA 210.69 2.95% | INTC 133.99 10.64% | WKSP 0.7379 23.33% | INLF 0.1566 -64.20% | NOK 13.49 -2.46% | AAL 15.99 3.70% | AZTR 0.1717 -15.42% | CAST 8.07 56.70% | CRVO 4.24 11.29% | NFLX 77.38 0.55% | AMC 2.83 6.39% | QS 8.04 16.52% | FLEX 147.61 3.13% | GRAB 3.57 3.48% | SOFI 17.91 2.81% | YYGH 0.0803 -37.70% | AAPL 298.01 0.70% | ATPC 3.88 42.12% | RKLB 107.24 -0.69% | BAC 56.2 -0.58% | LNKS 2.68 67.50% | SMCI 30.66 10.37% | PFE 25.22 -2.70% | SPY 746.74 0.78% | RIG 5.31 -4.84% | AMZN 244.39 2.90% | PLUG 2.85 7.55% | CRWV 117.95 2.38% | TSLL 13.16 1.86% | ONDS 9.27 1.64% | CMCSA 22.43 -1.15% | MU 1133.99 8.70% | TQQQ 82.87 6.87% | BFLY 8.9 55.87% | NVD 4.75 -5.57% | SQQQ 36.75 -7.01% | MSFT 379.4 0.13% | CTSH 43.7 -10.49% | WPRT 2.26 21.51% | T 22.01 -1.92%

AudioEye, Inc. (NASDAQ:AEYE) and Its Capital Efficiency Compared to Peers

AudioEye, Inc. (NASDAQ:AEYE) is a company that focuses on digital accessibility solutions, helping businesses make their digital content accessible to individuals with disabilities. The company operates in a competitive landscape with peers like Brightcove Inc., ClearPoint Neuro, Inc., Rekor Systems, Inc., DarioHealth Corp., and Apyx Medical Corporation. These companies, while operating in different sectors, share the common challenge of managing their capital efficiently.

AudioEye's Return on Invested Capital (ROIC) is -14.04%, which is significantly lower than its Weighted Average Cost of Capital (WACC) of 7.73%. This negative ROIC indicates that AudioEye is not generating enough returns to cover its cost of capital, which is a critical measure of financial health. The ROIC to WACC ratio of -1.82 further highlights this inefficiency in capital utilization.

When comparing AudioEye to its peers, Brightcove Inc. emerges as the company with the least negative ROIC to WACC ratio at -1.56. Despite its negative ROIC of -11.66%, Brightcove's WACC is 7.48%, suggesting it is relatively closer to covering its cost of capital compared to others. This positions Brightcove as a relatively better performer in terms of capital efficiency.

ClearPoint Neuro, Inc. and Rekor Systems, Inc. show more significant challenges with ROICs of -40.55% and -107.12%, respectively. Their ROIC to WACC ratios of -5.20 and -8.14 indicate a substantial gap between the returns generated and the cost of capital. This suggests that these companies face more significant hurdles in achieving capital efficiency.

DarioHealth Corp. and Apyx Medical Corporation also struggle with negative ROICs of -18.93% and -26.00%, respectively. Their ROIC to WACC ratios of -2.82 and -2.27 reflect ongoing challenges in generating returns that exceed their cost of capital. These figures underscore the broader issue of capital inefficiency across the peer group, with Brightcove Inc. standing out as the relatively better performer.

Published on: August 13, 2025